21 December 2015 in Cochrane Database of Systematic Reviews
2 April 2019 in Journal of Perinatology
1 December 2011 in Pediatrics
OBJECTIVE: To compare the efficacy of a porcine surfactant (poractant alfa) versus bovine surfactants (beractant and calfactant) with respect to clinical outcomes among preterm infants with respiratory distress syndrome. METHODS: A search of major electronic databases, including Medline (1980–2010) and the Cochrane Central Register of Controlled Trials, for randomized controlled trials that compared poractant alfa versus beractant and/or calfactant among preterm infants with respiratory distress syndrome who required intubation and surfactant treatment was performed. The primary outcome was oxygen requirement at a postmenstrual age of 36 weeks. RESULTS: Five randomized controlled trials involving 529 infants compared poractant alfa versus beractant for rescue treatment. No trials studied surfactant prophylaxis, and none compared poractant alfa versus calfactant. The incidences of oxygen dependence at a postmenstrual age of 36 weeks were similar for poractant alfa and beractant. Infants treated with poractant alfa at 100 mg/kg (low dose) or 200 mg/kg (high dose) exhibited statistically significant reductions in deaths (relative risk: 0.51 [95% confidence interval: 0.30–0.89]), the need for redosing (relative risk: 0.71 [95% confidence interval: 0.57–0.88]), oxygen requirements, duration of oxygen treatment, and duration of mechanical ventilation. The test of heterogeneity yielded positive results for the latter 2 outcomes. The difference remained statistically significant for deaths and the need for redosing with high-dose poractant alfa but not for low dose poractant alfa. CONCLUSIONS: There were significant reductions in deaths and the need for redosing with high-dose poractant alfa but not low-dose poractant alfa, compared with beractant.
18 August 2022 in Journal of Perinatology
3 August 2022 in Journal of Perinatology
NINational Emergency Airway Registry for Neonates (NEARNEOS) investigators
National Emergency Airway Registry for Neonates (NEARNEOS) investigators
+12
5 November 2018 in American Journal of Perinatology
Objective To compare the level of continuous positive airway pressure (CPAP) delivered by the RAM cannula system (Neotech, Valencia, CA) with that delivered by a traditional CPAP nasal delivery interface (Hudson prongs; Hudson-RCI, Temecula, CA) in preterm infants with respiratory distress. Methods This was a crossover intervention study in a convenience sample of preterm infants with respiratory distress requiring treatment with CPAP. We measured the mean intraoral (pharyngeal) pressure, which approximates the applied CPAP level, using both the RAM cannula and Hudson prongs. The primary outcome was a comparison of the differences between the set CPAP levels and the measured intraoral pressures of both delivery systems. Results We analyzed data from 12 preterm infants with mean (standard deviation) birth weight of 1,225 (405) g and gestational age of 28.4 (2.1) weeks at a median postnatal age of 10 days. The mean difference (95% confidence interval) between the set CPAP level and measured intraoral pressure was −2.45 cm H2O (−3.36, −1.55) with the RAM cannula and +0.40 cm H2O (−0.30, 1.12) with Hudson prongs, p = 0.0002. Conclusion For given set CPAP pressure level in preterm infants, the RAM cannula system consistently delivers lower pharyngeal pressure (effective CPAP) levels than Hudson prongs. Dr. Singh conceptualized and designed the study, drafted the initial article, and approved the final article as submitted. Matthew McNally was involved in study design, conducting the study, data collection, and analysis. Dr. Darnall developed the system to measure intraoral pressure, and was involved in designing the study and reviewing the article. ClinicalTrials.gov. ID: NCT03212508.